IFP Advisors’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
IFP Advisors's EIKN Position: Q3 2026 in Review
IFP Advisors increased its Eikon Therapeutics (EIKN) stake by 5.6% in Q3 2026, buying an estimated $513 and bringing the position to 969 shares worth $7.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.
IFP Advisors first reported a position in EIKN in Q2 2026 and has held it in 2 quarters since. The position peaked at $12K in Q2 2026. 95 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- IFP Advisors held 969 shares of Eikon Therapeutics worth $7.79K as of Q3 2026.
- IFP Advisors bought 51 Eikon Therapeutics shares in Q3 2026, an estimated $513.
- Eikon Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3554 holding.
- IFP Advisors first reported a position in Eikon Therapeutics in Q2 2026 and has held it in 2 quarters since.
- IFP Advisors's Eikon Therapeutics position peaked at $12K in Q2 2026.
- 95 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.